p53 mutation partially rescues developmental arrest in Brca1 and Brca2 null mice, suggesting a role for familial breast cancer genes in DNA damage repair.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations
BMC Cancer Open Access 30 November 2010
-
New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines
Breast Cancer Research Open Access 09 December 2005
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Miki, Y. et al. A strong candidate for the breast and ovarian-cancer susceptibility gene. Science 266, 66–71 (1994).
Wooster, R. et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 378, 789–792 (1995).
Coene, E. et al. BRCA1 is localized in cytoplasmic tube-like imaginations in the nucelus. Nature Genet. 16, 121–123 (1997).
Scully, R. et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell 88, 265–275 (1997).
Chapman, M.S. et al. Transcription activation by BRCA1. Nature 382, 678–679 (1996).
Milner, J. et al. Transcriptional activation functions in BRCA2. Nature 386, 772–773 (1997).
Sharan, S.K. et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386, 804–810 (1997).
Shinohara, A. et al. Rad51 protein involved in repair and recombination in S. Cerevesiae is a Rec-A like protein. Cell 69, 457–470 (1992).
Carr, A.M. et al. The cellular responses to DNA damage. TICS 5, 32–40 (1995).
Lim, D. et al. A mutation in rad 51 results in an early embryonic lethal that is suppressed by a mutationin p53. Mol. Cell. Biol. 16, 7133–7143 (1996).
Jacks, T. Tumor suppressor gene mutations in mice. Annu. Rev. Genet. 30, 603–636 (1996).
Hakem, R. et al. The tumor suppressor gene Brcal is required for embryonic cellular proliferation in the mouse. Cell 85, 1009–1023 (1996).
Liu, C. et al. Inactivation of the mouse Brcal gene leads to failure in the morphogenesis of the egg cylinder in early postimplantation development. Genes & Dev. 10, 1835–1843 (1996).
Ludwig, T. et al. Targeted mutations of breast cancer susceptibility gene homologs in mice: lethal. phenotypes of Brcal, Brca2, Brcal/Brca2, Brcal/p53, and Brca2/p53 nullizygous embryos. Genes & Dev. 11, 1226–1241 (1997).
Suzuki, A. et al. Brca2 is required for embryonic cellular proliferation in the mouse. Genes & Dev. 11, 1242–1252 (1997).
El-Deiry, W.S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817–825 (1993).
Brugarolas, J. et al. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377, 552–557 (1995).
Deng, C. et al. Mice Lacking p21 CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82, 675–684 (1995).
Hakem, R. et al. Rescue of Brca1 early embryonic lethality by p53 or p21 null mutation. Nature Genet. 16, 298–302 (1997).
Tsuzuki, T. et al. Targeted disruption of the Rad51 gene leads to lethality in embryonic mice. Proc. Natl. Acad. Sci. USA 93, 6236–6240 (1996).
Glebov, O.K. et al. Frequent p53 gene mutations and novel alleles in familial breast cancer. Cancer Res. 54, 3703–3709 (1994).
Boyd, M. et al. A human BRCA1 gene knockout. Nature 375, 541–542 (1995).
Jones, S.N. et al. Rescue of embryonic lethality in Mdm-2 deficient mice by absence of p53. Nature 378, 206–208 (1996).
Montes de Oca Luna, R. et al. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378, 203–206 (1995).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Brugarolas, J., Jacks, T. Double indemnity: p53, BRCA and cancer. Nat Med 3, 721–722 (1997). https://doi.org/10.1038/nm0797-721
Issue Date:
DOI: https://doi.org/10.1038/nm0797-721
This article is cited by
-
BRCA1-mutated and basal-like breast cancers have similar aCGH profiles and a high incidence of protein truncating TP53 mutations
BMC Cancer (2010)
-
Gene and chromosomal alterations in sporadic breast cancer: correlation with histopathological features and implications for genesis and progression
Breast Cancer (2009)
-
MDM2 SNP309 accelerates breast and ovarian carcinogenesis in BRCA1 and BRCA2 carriers of Jewish–Ashkenazi descent
Breast Cancer Research and Treatment (2008)
-
New role for nuclear hormone receptors and coactivators in regulation of BRCA1-mediated DNA repair in breast cancer cell lines
Breast Cancer Research (2005)
-
Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice
Oncogene (2001)
